Identification and therapeutic targeting of common arrhythmia trigger mechanisms

Arrhythmias are common manifestations of heart disease which frequently cause sudden cardiac death (SCD) or other devastating health problems. In Europe, prevention of SCD by device and drug therapy is expensive and increasingly strains public health resources due to a growing population at risk. However, identification of patients at increased risk for SCD is ineffective, and SCD prevention strategies are not directed at the underlying risk mechanisms.

Short name and number: 
EUTrigTreat (241526)
Name of US Partner: 
University of Maryland Biotechnology Institute
Contact: 

UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS (DE)

Participating Countries: 
Belgium
France
Germany
Greece
Italy
Switzerland
The Netherlands
United Kingdom
United States
Area: 

Health

Category: 

FP7 Project with U.S. partner